根据最终合并协议,Viewpoint的每一股已发行和流通股份将转换为获得Isoray 3.3212股的权利。Viewpoint股东将拥有Isoray完全稀释的流通股49%的股份。
$华海药业(SH600521)$ $华东医药(SZ000963...查看全文
$Isoray(ISR)$ 8-K Current report, items 2.02, 8.01, and 9.01 Accession Number: 0001437749-20-023369 Act: 34 Size: 937 KB 网页链接
$Isoray(ISR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-20-021859 Size: 7 KB 网页链接
$Isoray(ISR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-20-021846 Size: 7 KB 网页链接
$Isoray(ISR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-20-021861 Size: 7 KB 网页链接
$Isoray(ISR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-20-021853 Size: 6 KB 网页链接
$Isoray(ISR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-20-021855 Size: 7 KB 网页链接
$Isoray(ISR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-20-021857 Size: 7 KB 网页链接
$Isoray(ISR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-20-021849 Size: 7 KB 网页链接
$Isoray(ISR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-20-021851 Size: 7 KB 网页链接
$Isoray(ISR)$ DEF 14A Other definitive proxy statements Accession Number: 0001437749-20-021715 Act: 34 Size: 684 KB 网页链接